Recent Announcements Suggest Cellceutix Is Well Positioned With Autism Compound

With biomedical research and pharmaceutical development happening all over the world, it is exciting to see companies now finding a new interest in Autism and ASD. Cellceutix recently indicated that they are in a position to move forward with Autism treatment research.

"These announcements indicate that Cellceutix is in a prime position in the development of treatments for autism spectrum disorder," said Leo Ehrlich, the Chief Financial Officer of Cellceutix. "We are developing a novel compound for a disorder which has few treatment options. In an area that people were once skeptical about pharmaceutical advancements being possible, it is encouraging to see other companies showing significant interest."

Read more about this on the MarketWatch.

Cellceutix acquired the rights to KM-391, its compound for the treatment of autism spectrum disorder, last year and has been diligently developing the compound since. Cellceutix has already completed an animal study that shows very encouraging results. Details of the data from the study are available at the Cellceutix website at www.cellceutix.com.

More on diets and Autsim...

The verdict seems to be up in the air regarding diets and Autism. Some studies have shown that certain diets can help children suffering from Autism, as we mentioned in the last post.

A recent article posted by WebMD however, uncovers results found by the University of Texas at Austin conveying that glutton-free and casein-free diets do not seem to show any impact on improving Autism symptoms.

You can read the article here.

Interesting article with useful information. As research progresses, we hope to learn more about effective approaches to helping individuals with ASDs.

Alternative Approaches to Autism

According to the CDC's December, 2009 ADDM autism prevalence report, 1 in every 110 American children is diagnosed with autism spectrum disorder; for boys, the odds increase to 1 in 70. The Autism Society estimates that the lifetime cost of caring for a child with autism ranges from $3.5 million to $5 million; and the United States spends almost $90 billion annually on ASD related costs for research, educational spending, housing, transportation, insurance costs and non-covered expenses and Medicaid waivers for autism, not to mention related therapeutic services and caregiver costs (CDC, 2010).

Although many resources are available for parents of children with Autism, many are still desperate to find alternative techniques and therapies that could help their child move even further. In fact, 1 in 5 parents of children with autism are currently relying on some sort of non-conventional therapy for autism, according to research presented at the annual Pediatric Academic Societies meeting in Vancouver this weekend (Thornton, 2010).

The most common alternative treatments for autism involve placing affected children on a special diet, with quite a bit of anecdotal evidence, at least, showing that special diets help improve the behavior and quality of life among those with ASD. The most common special diets among children with autism are gluten free, dairy free or both (Thornton, 2010).

Diets, picky eating, trouble in digestion and food intake are hot topics in ASD community and this subject has been discussed previously on this ; refer to: this post.


To read more about alternative approaches to autism, you can find this article by the Dallas Healthy Trends Examiner.